Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis.

With regard to the unexpected finding of an increasing trend in INL volume in responder patients, the underlying mechanism remains unclear, although an ocrelizumab-mediated effect on the local cellular network has to be taken into account.

also in 63,971 other papers